GC Aesthetics, Ltd., a Dublin, Ireland-based designer, manufacturer, and distributor of medical devices for the global aesthetics industry, received a US$30m private equity investment from Montreux Equity Partners, LLC.
The funds will help the company accelerate its expansion plans. Commenting on the financing, Ken Pearce, CEO of GCAL, said: “This investment allows us to expand the global reach of our products in this rapidly growing sector”.
The company already supplies customers in 90 countries around the world, including Europe, Asia, and South America.
In conjunction with the agreement, Daniel K. Turner III, Managing Director at Montreux, joins the board of directors of GCAL as Chairman. Howard Palefsky, Montreux Managing Director, also takes a seat on the board.